Abbott Laboratories

ABT

$127.44

+22.8% (1 year change)

Ray Dalio Holding value: $229 Million Jeremy Grantham Holding value: $221 Million Ken Griffin Holding value: $58.5 Million Joel Greenblatt Holding value: $7.18 Million Mario Gabelli Holding value: $3.05 Million Tom Russo Holding value: $1.53 Million Jim Simons Holding value: $0 Chuck Akre Holding value: $0 Tom Gayner Holding value: $0 Daniel Loeb Holding value: $0 Chris Davis Holding value: $0 Stanley Druckenmiller Holding value: $0 George Soros Holding value: $0 Bill Gates Holding value: $0 Donald Yacktman Holding value: $0 David Tepper Holding value: $0 Prem Watsa Holding value: $0

Market Cap

$227 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$98.86 - $129.52

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

35.58x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$1.70 (1.33%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $227 Billion
Enterprise Value $236 Billion
Dividend Yield $1.70 (1.33%)
1 Year Return +24.1%
52-Week High $129.52
52-Week Low $98.86
Beta 0.57
Outstanding Shares 1.77 Billion
Avg 30 Day Volume 3.93 Million

Valuation

P/E Ratio 35.58
PEG 16.33
Earnings per Share $3.56
Price to Sales Ratio 6.07
Price to Book Ratio 6.71
Revenue to Enterprise Value 6.33
EBIT to Enterprise Value 35.25
Total Debt to Enterprise Value 0.08
Debt to Equity 0.55

Profitability

Revenue $37.3 Billion
Gross Profit $21.2 Billion
EBIT $6.71 Billion
Net Income $5.72 Billion
Profit Margin 15.33%
Quarterly Earnings Growth (YoY) +217.9%
Return on Equity 16.93%
Return on Assets 7.81%
Return on Invested Capital 11.06%

News

mHealth Apps Market Size, Landscape, Industry Analysis, Business Outlook, Opportunities, Key Companies, Current and Future Growth By 2028 | Novartis AG, Johnson and Johnson, Abbott Laboratories, Bristol-Myers Squibb Company., GlaxoSmithKline plc., Pfizer,

mHealth Apps Market Size, Landscape, Industry Analysis, Business Outlook, Opportunities, Key Companies, Current and Future Growth By 2028 | Novartis AG, Johnson and Johnson, Abbott Laboratories, Bristol-Myers Squibb Company., GlaxoSmithKline plc., Pfizer,

The mHealth Apps Market report is analyzed on the basis of its market share by value and volume. The report includes regional, country, and global analyses of all Smart Camera segments. The study e...

OpenPR OpenPR, about 21 hours ago
Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President''s New OSHA Mandates

Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President''s New OSHA Mandates

VANCOUVER, BC , Sept. 14, 2021 /PRNewswire/ -- USA News Group - More than 80 million workers in the United States are now facing a new vaccine/testing mandate being pushed by the Biden Administrati...

Benzinga Benzinga, 3 days ago
Future outlook of Minimally Invasive Surgical Instruments Market 2021-2027 | Key Players: Medtronic Plc, Ethicon, Inc., Stryker Corporation, Smith & Nephew Plc, Abbott Laboratories, Conmed Corporation

Future outlook of Minimally Invasive Surgical Instruments Market 2021-2027 | Key Players: Medtronic Plc, Ethicon, Inc., Stryker Corporation, Smith & Nephew Plc, Abbott Laboratories, Conmed Corporation

Minimally Invasive Surgical Instruments Market research report is the new statistical data source added by A2Z Market Research. The key factors that drive the growth of the minimally invasive surgi...

OpenPR OpenPR, 4 days ago
To improve your user experience we use cookies.